A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
Top Cited Papers
- 21 August 2007
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 50 (14) , 1373-1380
- https://doi.org/10.1016/j.jacc.2007.06.047
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery StentsJournal of the American College of Cardiology, 2007
- Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery: An Intravascular Ultrasound StudyJournal of the American College of Cardiology, 2007
- Treatment of In-Stent Restenosis — Back to the Future?New England Journal of Medicine, 2006
- Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery DiseaseCirculation, 2006
- Trading Restenosis for Thrombosis? New Questions about Drug-Eluting StentsNew England Journal of Medicine, 2006
- Review of Randomized Clinical Trials of Drug-Eluting Stents for the Prevention of In-Stent Restenosis††All study acronyms used in this review are defined in Table 1.The American Journal of Cardiology, 2006
- “Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study”Catheterization and Cardiovascular Interventions, 2006
- The Paclitaxel-Eluting Stent in Percutaneous Coronary Intervention: Part IICardiology in Review, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986